High-Dose Daptomycin for Treatment of Complicated Gram-Positive Infections: A Large, Multicenter, Retrospective StudyKULLAR, Ravina; DAVIS, Susan L; LEVINE, Donald P et al.Pharmacotherapy. 2011, Vol 31, Num 6, pp 527-536, issn 0277-0008, 10 p.Article

Safety and Clinical Outcomes when Utilizing High-Dose (≥8 mg/kg) Daptomycin TherapyMOISE, Pamela A; HERSHBERGER, Ellie; AMODIO-GROTON, Maria I et al.The Annals of pharmacotherapy. 2009, Vol 43, Num 7-8, pp 1211-1219, issn 1060-0280, 9 p.Article

Telavancin : An Antimicrobial with a Multifunctional Mechanism of Action for the Treatment of Serious Gram-Positive InfectionsLEONARD, Steven N; RYBAK, Michael J.Pharmacotherapy. 2008, Vol 28, Num 4, pp 458-468, issn 0277-0008, 11 p.Article

Le linézolide (Zyvoxid®) = Linezolid (Zyvoxid®)VAN LAETHEM, Y; STERNON, J.Revue médicale de Bruxelles. 2004, Vol 25, Num 1, pp 47-50, issn 0035-3639, 4 p.Article

Clinical experience with daptomycin in Europe: the first 2.5 yearsGONZALEZ-RUIZ, Armando; BEIRAS-FERNANDEZ, Andres; LEHMKUHL, Hans et al.Journal of antimicrobial chemotherapy (Print). 2011, Vol 66, Num 4, pp 912-919, issn 0305-7453, 8 p.Article

Peptidoglycan of S. aureus causes increased levels of matrix metalloproteinases in the ratWANG, Jacob E; PETTERSEN, Solveig; STUESTOL, Jon Fredrik et al.Shock (Augusta, Ga.). 2004, Vol 22, Num 4, pp 376-379, issn 1073-2322, 4 p.Article

Pre-clinical experience with daptomycinHAWKEY, P. M.Journal of antimicrobial chemotherapy (Print). 2008, Vol 62, issn 0305-7453, iii7-iii14, SUP3Article

Future treatment options for Gram-positive infections—looking aheadBARTON, E; MACGOWAN, A.Clinical microbiology and infection. Supplement. 2009, Vol 15, Num 6, pp 17-25, issn 1470-9465, 9 p.Conference Paper

Evaluation of the in vitro activity of daptomycin against 19615 clinical isolates of Gram-positive cocci collected in North American hospitals (2002-2005)PFALLER, Michael A; SADER, Helio S; JONESB, Ronald N et al.Diagnostic microbiology and infectious disease. 2007, Vol 57, Num 4, pp 459-465, issn 0732-8893, 7 p.Article

Maximizing positive outcomes for patients with staphylococcal infectionsSTAHL, J.-P.Clinical microbiology and infection. Supplement. 2009, Vol 15, Num 6, pp 26-32, issn 1470-9465, 7 p.Conference Paper

Future directions with daptomycinLIVERMORE, David M.Journal of antimicrobial chemotherapy (Print). 2008, Vol 62, issn 0305-7453, iii41-iii49, SUP3Article

In vitro activity and killing effect of temporin A on nosocomial isolates of Enterococcus faecalis and interactions with clinically used antibioticsGIACOMETTI, Andrea; CIRIONI, Oscar; KAMYSZ, Wojciech et al.Journal of antimicrobial chemotherapy (Print). 2005, Vol 55, Num 2, pp 272-274, issn 0305-7453, 3 p.Article

Peptidoglycan of staphyloccus aureus induces enhanced levels of matrix metalloproteinase-9 in human blood originating from neutrophilsYUN YONG WANG; MYHRE, Anders E; PETTERSEN, Solveig J et al.Shock (Augusta, Ga.). 2005, Vol 24, Num 3, pp 214-218, issn 1073-2322, 5 p.Article

A consensus statement on empiric therapy for suspected gram-positive infections in surgical patientsSOLOMKIN, Joseph S; BJORNSON, H. Stephen; NAPOLITANO, Lena et al.The American journal of surgery. 2004, Vol 187, Num 1, pp 134-145, issn 0002-9610, 12 p.Article

Linezolid versus vancomycin for the treatment of Gram-positive bacterial infections: meta-analysis of randomised controlled trialsLIANG BEIBEI; CAI YUN; CHEN MENGLI et al.International journal of antimicrobial agents (Print). 2010, Vol 35, Num 1, pp 3-12, issn 0924-8579, 10 p.Article

Efficacy and safety of daptomycin in the treatment of Gram-positive catheter-related bloodstream infections in cancer patientsCHAFTARI, Anne-Marie; HACHEM, Ray; MULANOVICH, Victor et al.International journal of antimicrobial agents (Print). 2010, Vol 36, Num 2, pp 182-186, issn 0924-8579, 5 p.Article

Continuous versus intermittent infusion of vancomycin for the treatment of Gram-positive infections: systematic review and meta-analysisCATALDO, Maria Adriana; TACCONELLI, Evelina; GRILLI, Elisabetta et al.Journal of antimicrobial chemotherapy (Print). 2012, Vol 67, Num 1, pp 17-24, issn 0305-7453, 8 p.Article

Clinical outcomes with daptomycin: a post-marketing, real-world evaluationSAKOULAS, G.Clinical microbiology and infection. Supplement. 2009, Vol 15, Num 6, pp 11-16, issn 1470-9465, 6 p.Conference Paper

The use of linezolid in the treatment of paediatric patients with infections caused by enterococci including strains resistant to vancomycinDEVILLE, Jaime G; GOLDFARB, Johanna; KAPLAN, Sheldon L et al.Journal of antimicrobial chemotherapy (Print). 2010, Vol 65, Num 10, pp 2267-2270, issn 0305-7453, 4 p.Article

Empirical therapy for serious Gram-positive infections: making the right choiceSEGRETI, J.Clinical microbiology and infection. Supplement. 2009, Vol 15, Num 6, pp 5-10, issn 1470-9465, 6 p.Conference Paper

Key considerations in the treatment of complicated staphylococcal infectionsJONES, R. N.Clinical microbiology and infection. Supplement. 2008, Vol 14, Num 2, pp 3-9, issn 1470-9465, 7 p.Conference Paper

Linezolid cerebrospinal fluid concentration in central nervous system infectionMALACARNE, P; VIAGGI, B; DI PAOLO, A et al.Journal of chemotherapy. 2007, Vol 19, Num 1, pp 90-93, issn 1120-009X, 4 p.Article

Pharmacokinetics and effects on bowel and throat microflora of oral levofloxacin as antibacterial prophylaxis in neutropenic patients with haematological malignanciesTIMMERS, G. J; DIJSTELBLOEM, Y; SIMOONS-SMIT, A. M et al.Bone marrow transplantation (Basingstoke). 2004, Vol 33, Num 8, pp 847-853, issn 0268-3369, 7 p.Article

Safety of Daptomycin in Patients Receiving HemodialysisMUELLER, Bruce A; CROMPTON, Jason A; DONOVAN, Brian J et al.Pharmacotherapy. 2011, Vol 31, Num 7, pp 665-672, issn 0277-0008, 8 p.Article

Treatment challenges in the management of complicated skin and soft-tissue infectionsEISENSTEIN, B. I.Clinical microbiology and infection. Supplement. 2008, Vol 14, Num 2, pp 17-25, issn 1470-9465, 9 p.Conference Paper